Learn more about our work, our members and our commitment to curing pediatric cancer.

For press inquiries, please contact

Researchers Identify Factors Associated With CAR-T Resistance in B-ALL

Dr Orentas discusses CAR-T resistance in patients with B-cell acute lymphoblastic leukemia (B-ALL) and results from an analysis presented at the 2019 ASH Annual Meeting.


Children’s National Hospital Hosts CureWorks Scientific and Medical Review Committee Meeting

The 2nd annual Scientific and Medical Review Committee meeting was held in WA DC at Children’s National Hospital.


Riley Children’s Health joins CureWorks collaborative

Riley Children’s Health at Indiana University Health is proud to become the only CureWorks member hospital in the Midwest. This unique collaboration will allow Riley oncologists and Indiana University School of Medicine researchers greater access to cutting-edge immunotherapy trials for pediatric oncology patients.


Pediatric CAR T-Cell Immunotherapy Trial Aims to Improve Remission Rates of Leukemia at Children’s National Health System

Children’s National Health System announces the opening of a chimeric antigen receptor (CAR) T-cell immunotherapy trial for pediatric patients with relapsed or refractory acute lymphoblastic leukemia (ALL). Children’s National is now the second hospital in the country to offer the PLAT-05 trial after it first launched at Seattle Children’s.


Seattle Children’s launches into solid tumor treatments with new CAR T immunotherapy trial

Seattle Children’s Research Institute is launching a clinical trial that will examine a new kind of cancer-fighting treatment. The treatment is a type of CAR T immunotherapy, which reprograms a person’s immune cells to find and destroy cancer.


Seattle Children’s launches CureWorks, a project aimed at revolutionizing cancer treatment for kids

New cancer immunotherapies could revolutionize how we treat the disease, but for many children, those treatments are far out of reach.


Seattle Children's Hospital launches immunotherapy collaborative to expand clinical trial access at children's hospitals

Four academic children's hospitals have joined forces to create a research collaborative that will make it easier for their patients to access immunotherapy clinical trials and for their researchers to find good candidates for therapies.


BC Children’s Hospital joins international collaborative to further the development of innovative immunotherapy treatments for kids with hard-to-treat cancer

Vancouver, BC — BC Children’s Hospital has joined CureWorks, an international collaborative of leading academic children’s hospitals focused on improving care for children with hard-to-treat cancers by expanding clinical trials and accelerating the development of leading-edge immunotherapy treatments.